Seeing Is Believing
Healthcare - Sector
EBS is currently covered by 3 analysts with an average price target of $11. This is a potential upside of $4.77 (76.57%) from yesterday's end of day stock price of $6.23.
Emergent Biosolutions's activity chart (see below) currently has 127 price targets and 105 ratings on display. The stock rating distribution of EBS is 88.89% BUY and 11.11% SELL.
Analysts average stock forecasts to be materialized ratio is 65.53% with an average time for these price targets to be met of 151.79 days.
Highest price target for EBS is $12, Lowest price target is $10, average price target is $11.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 27-Sep-2017.
Currently out of the existing stock ratings of EBS, 8 are a BUY (88.89%), 1 are a SELL (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Dec-2024
$10
$3.67 (57.98%)
$10
1 months 15 days ago
(09-Sep-2026)
0/14 (0%)
$4.32 (76.06%)
Sell Since 20-Nov-2023
2 months 3 days ago
(21-Aug-2026)
2/3 (66.67%)
$0.88 (10.84%)
7
Buy Since 11-Apr-2024
$12
$3.47 (40.68%)
$8
1 years 11 months 17 days ago
(07-Nov-2024)
7/11 (63.64%)
$1 (9.09%)
72
Buy Since 13-Sep-2024
$16
$9.67 (152.76%)
$23
2 years 1 months 11 days ago
(13-Sep-2024)
10/15 (66.67%)
$8.13 (103.30%)
135
Hold Since 12-Sep-2022
$15
$8.67 (136.97%)
$29
3 years 5 months 5 days ago
(19-May-2023)
4/8 (50%)
$6.83 (83.60%)
86
What is EBS (Emergent Biosolutions) average time for price targets to be met?
Which analyst most recently updated their price target on EBS (Emergent Biosolutions)?
Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?
Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?
Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?